Product information
- Product Line
- Human Formulations
- Category
- Oral Liquids, Dry Syrup
- Dosage Form
- Oral Suspension / Dry Syrup
- Product Type
- Single Ingredient
Available strengths
Cefixime 50 mg + Lactobacillus 100 Million Spores / 5mlCefixime 50 mg + Lactobacillus 20 Million Spores / 5mlCefixime 50 mg + Lactobacillus 40 Million Spores / 5mlCefixime 50 mg + Lactobacillus 60 Million Spores /5ml
Description
Cefixime 50 mg + Lactobacillus 100 Million Spores / 5ml is a oral suspension / dry syrup formulated with Cefixime 50 mg + Lactobacillus 100 Million Spores / 5ml. The listed active ingredient profile is Cefixime; Lactobacillus Spores, placing the product in the antibiotic + probiotic combination category. The antibacterial component treats susceptible bacterial infection while the probiotic component is included as supportive gastrointestinal care. The liquid presentation is supplied as an oral suspension/dry-syrup product; reconstitution, shaking, storage and discard instructions must follow the approved label. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.